Jefferies Financial Group Inc. Xenon Pharmaceuticals Inc. Put Options Transaction History

Jefferies Financial Group Inc.

  • $13.5 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 13, 2024
SELL
$42.66 - $50.04 $738,017 - $865,692
-17,300 Reduced 40.71%
25,200 $1.08 Million
Q4 2023

Feb 13, 2024
BUY
$28.7 - $46.46 $407,540 - $659,732
14,200 Added 50.18%
42,500 $1.96 Million
Q2 2023

Aug 14, 2023
BUY
$34.84 - $43.54 $414,596 - $518,126
11,900 Added 72.56%
28,300 $1.09 Million
Q4 2022

Sep 21, 2023
SELL
$33.06 - $39.43 $393,414 - $469,217
-11,900 Reduced 42.05%
16,400 $646,000
Q4 2022

Feb 14, 2023
BUY
$33.06 - $39.43 $542,184 - $646,652
16,400 New
16,400 $646,000

Others Institutions Holding XENE

# of Institutions
212
Shares Held
70.2M
Call Options Held
88.3K
Put Options Held
28.8K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.42B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email